Evaluation of Gas Humidification Practices in Patients Under Invasive Mechanical Ventilation
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: MR850, FP950.
- Who it may be relevant to
- Registry conditions: Humidifier Lung, Mechanical Fragility, Respiratory Complication. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Canada
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Evaluation of Gas Humidification Practices in Patients Under Invasive Mechanical Ventilation: Benefit of the F & P950 Heated Humidifier: Comparison With the MR 850 on Clinical Events of Under-humidification
Overview
When mechanical ventilation is initiated, a humidification method should be chosen. There is two methods: heat and humidity exchanger filters or heated humidity. The second method is recognized to be more efficient, but many external factors can influence its performance. Insufficient humidity results in observable problems, such as difficult management of respiratory secretions. The study compare two heated humidifiers already used in ICU. Data will be collected retrospectively from June 1, 2021.
Interventions
- Device MR850
This humidifier will be used straight away for patients whose intubation is expected to last longer than 24 hours. - Device FP950
This humidifier will be used straight away for patients whose intubation is expected to last longer than 24 hours.
Primary outcome measures
- Endotracheal tube occlusion requiring emergency tube change [Time frame: At the end of the mechanical ventilation period or at 21 days ( the first of the 2 occurred)]
- Bronchoscopy [Time frame: At the end of the mechanical ventilation period or at 21 days ( the first of the 2 occurred)]
- Tracheal saline instillations [Time frame: At the end of the mechanical ventilation period or at 21 days ( the first of the 2 occurred)]
- Thick secretions [Time frame: At the end of the mechanical ventilation period or at 21 days ( the first of the 2 occurred)]
- Change humidifier settings [Time frame: At the end of the mechanical ventilation period or at 21 days ( the first of the 2 occurred)]
Secondary outcome measures (1)
- Other elements that may be influenced by the quality of the humidification used during mechanical ventilation [Time frame: At the end of the mechanical ventilation period or at 21 days ( the first of the 2 occurred)]
Eligibility criteria
Inclusion criteria
- ≥ 18 years old
- Admitted to intensive care
- Under invasive mechanical ventilation with the usual indications for the use of a heated humidifier (prolonged invasive mechanical ventilation and / or protective ventilation requiring high respiratory rates.
Exclusion criteria
- Mechanical venitilation immediately after surgery (<24h)
- Imminent extubation or planned intubation of very short duration (<24h)
- Enrolled in the SAVE-ICU study in the group receiving volatile agents with the AnaConDa system.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Study design
- Observational model
- Cohort
Study locations
Canada · 1 center
- Institut Universitaire de Cardiologie et de Pneumologie de Québec — Québec
Identifiers
NCT: NCT06719258 · 2022-3714